Publications by authors named "Divya Sanjaykumar Desai"
Objective: To review data on efficacy and safety of osilodrostat (Isturisa), a novel oral steroidogenesis inhibitor for treatment of Cushing's disease (CD), a life-threatening endocrine disorder.
Data Sources: A PubMed/CINAHL search from inception to September 25, 2020, was performed using the following keywords: , and .
Study Selection And Data Extraction: Phase 2 and 3 clinical trials and supplementary documents investigating osilodrostat were obtained from a primary literature search, the manufacturer's website, and the Food and Drug Administration website.